Extended-spectrum and CMY-type β-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain

Clinical Microbiology and Infection

Volumn 16, Issue 1, 2010, Pages 33-38

  Doi, Y ^a   Paterson, D L ^a,b   Egea, P ^c   Pascual, A ^c   Lopez Cerero L ^c   Navarro, M D ^d   Adams Haduch, J M ^a   Qureshi, Z A ^a   Sidjabat, H E ^a,b   Rodriguez Bano J ^d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Servicio de Microbiologia   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Antimicrobial resistance; Clinical epidemiology; CMY type lactamases; Escherichia coli; Extended spectrum lactamases; Food; Molecular epidemiology; lactamases

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE SHV; CEFOTAXIME; CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHICKEN; CLUSTER ANALYSIS; COMMUNICABLE DISEASE; CULTURE MEDIUM; DISEASE CARRIER; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FOOD CONTAMINATION; GENETIC ANALYSIS; HUMAN; INCUBATION TIME; MEAT INDUSTRY; MOLECULAR TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PORK; PRIORITY JOURNAL; SAMPLING; SPAIN; UNITED STATES;

ESCHERICHIA COLI; GALLUS GALLUS;

EID: 71849109407     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03001.x     Document Type: Article

References (31)

1. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
2. Bauernfeind A, Horl G. Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporins. Infection 1987, 15:257-259.
3. Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 1989, 17:316-321.
4. Jacoby GA. AmpC β-lactamases. Clin Microbiol Rev 2009, 22:161-182.
5. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
6. Pitout JD, Gregson DB, Church DL, Laupland KB. Population-based laboratory surveillance for AmpC β-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 2007, 13:443-448.
7. Sidjabat HE, Paterson DL, Qureshi ZA. Clinical features and molecular epidemiology of CMY-type β-lactamase-producing Escherichia coli. Clin Infect Dis 2009, 48:739-744.
8. Hanson ND, Moland ES, Hong SG. Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob Agents Chemother 2008, 52:3814-3816.
9. Kang CI, Kim SH, Park WB. Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 2004, 48:4574-4581.
10. Rodriguez-Bano J, Navarro MD, Romero L. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006, 43:1407-1414.
11. Rodriguez-Bano J, Alcalá JC, Cisneros JM. Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Arch Intern Med 2008, 168:1897-1902.
12. Rodriguez-Bano J, Navarro MD, Romero L. Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004, 42:1089-1094.
13. Carattoli A. Animal reservoirs for extended spectrum β-lactamase producers. Clin Microbiol Infect 2008, 14(suppl 1):117-123.
14. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. 2006, Wayne, PA: CLSI
15. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
16. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
17. Friedman ND, Kaye KS, Stout JE. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
18. Garcia Dde O, Doi Y, Szabo D. Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum β-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil. Antimicrob Agents Chemother 2008, 52:1790-1793.
19. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555-4558.
20. Tenover FC, Arbeit RD, Goering RV. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
21. Wiener J, Quinn JP, Bradford PA. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999, 281:517-523.
22. Trick WE, Weinstein RA, DeMarais PL. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001, 49:270-276.
23. Rodríguez-Baño J, Alcalá J, Cisneros JM. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. J Antimicrob Chemother 2009, 63:781-784.
24. Li XZ, Mehrotra M, Ghimire S. β-Lactam resistance and β-lactamases in bacteria of animal origin. Vet Microbiol 2007, 121:197-214.
25. Jouini A, Vinue L, Slama KB. Characterization of CTX-M and SHV extended-spectrum β-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J Antimicrob Chemother 2007, 60:1137-1141.
26. Mesa RJ, Blanc V, Blanch AR. Extended-spectrum β-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). J Antimicrob Chemother 2006, 58:211-215.
27. Jensen LB, Hasman H, Agerso Y. First description of an oxyimino-cephalosporin-resistant, ESBL-carrying Escherichia coli isolated from meat sold in Denmark. J Antimicrob Chemother 2006, 57:793-794.
28. Warren RE, Ensor VM, O'Neill P. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2008, 61:504-508.
29. Johnson JR, Sannes MR, Croy C. Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis 2007, 13:838-846.
30. Johnson JR, McCabe JS, White DG. Molecular analysis of Escherichia coli from retail meats (2002-2004) from the United States National Antimicrobial Resistance Monitoring System. Clin Infect Dis 2009, 49:195-201.
31. Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors, and molecular epidemiology. J Antimicrob Chemother 2008, 62:1142-1149.